122 related articles for article (PubMed ID: 15105062)
1. Lipid profile in women over 35 years old using triphasic combined oral contraceptives.
Aldrighi JM; Petta CA; Bahamondes L; Caetano ME; Martinez TR; De Lima GR
Contraception; 2004 May; 69(5):395-9. PubMed ID: 15105062
[TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
[TBL] [Abstract][Full Text] [Related]
4. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Tuppurainen M; Klimscheffskij R; Venhola M; Dieben TO
Contraception; 2004 May; 69(5):389-94. PubMed ID: 15105061
[TBL] [Abstract][Full Text] [Related]
5. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
7. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
8. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Creasy GW; Fisher AC; Hall N; Shangold GA
J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
Guazzelli CA; Lindsey PC; de Araújo FF; Barbieri M; Petta CA; Aldrighi JM
Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
[TBL] [Abstract][Full Text] [Related]
10. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene. A 12-month trial.
Moutos DM; Zacur HA; Bachorik PS; Wallach EE
J Reprod Med; 1994 Sep; 39(9):720-4. PubMed ID: 7807486
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use.
Rad M; Kluft C; de Kam ML; Meijer P; Cohen AF; Grubb GS; Constantine GD; Burggraaf J
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):85-94. PubMed ID: 21417560
[TBL] [Abstract][Full Text] [Related]
13. [Effects of oral contraceptive preparations and smoking on lipoprotein repartition].
Foulon T; Payen N; Groslambert P; Bijaoui S; Dupont G; Roland F; Laporte F
Ann Biol Clin (Paris); 1999; 57(5):573-8. PubMed ID: 10518059
[TBL] [Abstract][Full Text] [Related]
14. The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
Köse K; Doğan P; Ozesmi C
Biochem Mol Biol Int; 1993 Jun; 30(2):245-52. PubMed ID: 8364406
[TBL] [Abstract][Full Text] [Related]
15. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
[TBL] [Abstract][Full Text] [Related]
17. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
[TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids in women on oral contraceptives in Zaria-Nigeria.
Yahaya IA; Afonja OA
Niger Postgrad Med J; 2005 Jun; 12(2):85-8. PubMed ID: 15997254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
